Breaking News Instant updates and real-time market news.

DVA

DaVita

$64.77

-0.11 (-0.17%)

08:25
05/25/17
05/25
08:25
05/25/17
08:25

DaVita to hold capital markets day with a conference call hookup

Capital Markets Day will be held in New York on May 25 at 8:30 am. Webcast Link

  • 25

    May

  • 25

    May

DVA DaVita
$64.77

-0.11 (-0.17%)

12/13/16
12/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deutsche Bank analyst Bill Schmitz downgraded Procter & Gamble (PG) to Hold citing a lack of catalysts over the next few quarters. The analyst lowered his price target for P&G shares to $90 from $95 but remains positive on P&G's medium to long-term opportunity. Schmitz also downgraded Coca-Cola (KO) to Hold saying that while CEO James Quincey "is the right person for the turnaround job," near-term stock outperformance will be limited by investor migration out of staples, wellness related consumption headwinds and likely negative earnings revisions. The analyst cut his price target for Coca-Cola shares to $44 from $48. 2. Barclays analyst Karen Short downgraded GNC Holdings (GNC) to Underweight saying the company's recent strategy change and press reports indicating that at least some potential foreign buyers are not interested in the U.S. assets make a potential takeover unlikely. 3. RBC Capital downgraded Viacom (VIAB) to Underperform from Sector Perform after the company announced that it would no longer pursue a merger with CBS (CBS). Wedbush analyst James Dix also downgraded Viacom to Neutral after National Amusements withdrew support for a merger with CBS. 4. Craig-Hallum analyst Chad Bennett downgraded Model N (MODN) to Hold saying the "risks outweigh the benefits" following the company's acquisition of primary competitor Revitas. 5. Baird analyst Whit Mayo downgraded DaVita (DVA) to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/16
12/13/16
DOWNGRADE
Target $69

Neutral
DaVita downgraded to Neutral after CMS guidance at Baird
As previously reported, Baird analyst Whit Mayo downgraded DaVita to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. Mayo, who also cites the stock's 20% bounce off of its bottom and the company's "tepid" organic growth, sees DaVita shares "trading sideways" in the near-term. He raised his price target on DaVita to $69 from $68.
12/13/16
BARD
12/13/16
DOWNGRADE
BARD
Neutral
DaVita downgraded to Neutral from Outperform at Baird
11/01/16
BARD
11/01/16
NO CHANGE
Target $68
BARD
Outperform
DaVita price target lowered to $68 from $85 at Baird
Baird analyst Whit Mayo lowered his price target on DaVita to $68 from $85 following the company's better than feared announcement of its potential $230M hit from on-exchange and off-exchange patients related to a potential CMS ruling regarding charitable premium assistance for ESRD patients. The analyst cut his estimates, although he feels the announcement de-risks the stock. Mayo maintained his Outperform rating on DaVita shares.

TODAY'S FREE FLY STORIES

PPG

PPG

$106.37

-0.35 (-0.33%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXAS

Abraxas Petroleum

$1.61

-0.04 (-2.42%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Initiation
Abraxas Petroleum initiated  »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

CALM

Cal-Maine Foods

$37.10

1 (2.77%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Cal-Maine Foods reports Q4 EPS (51c) with items, consensus (25c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

SGMS

Scientific Games

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Scientific Games reports Q2 EPS (44c), consensus (52c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Hot Stocks
Hasbro CEO says entered 2H with 'strong consumer momentum' »

"The Hasbro team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

HAS

Hasbro

$115.95

1.05 (0.91%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Hot Stocks
Hasbro CFO says seeing 'some softness' in Brazil, U.K. »

"Our balance sheet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

ALRN

Aileron Therapeutics

$12.78

-0.14 (-1.08%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Initiation
Aileron Therapeutics initiated  »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$2.95

-0.1 (-3.28%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Conference/Events
Catalyst Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Earnings
Hasbro reports Q2 EPS 53c, consensus 46c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

VLO

Valero

$67.78

0.26 (0.39%)

, PSX

Phillips 66

$82.85

0.49 (0.59%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Periodicals
U.S. mulls financial sanctions on Venezuela's PDVSA, Reuters reports »

The Trump administration…

VLO

Valero

$67.78

0.26 (0.39%)

PSX

Phillips 66

$82.85

0.49 (0.59%)

CVX

Chevron

$103.25

-1.38 (-1.32%)

PBF

PBF Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

  • 01

    Aug

  • 03

    Aug

KCDMY

Kimberly-Clark de Mexico

$10.34

-0.3 (-2.82%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$106.37

-0.35 (-0.33%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Downgrade
PPG rating change  »

PPG downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$37.40

-1.1 (-2.86%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Floor & Decor rating change  »

Floor & Decor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BABA

Alibaba

$151.89

-0.22 (-0.14%)

, MGI

MoneyGram

$16.56

-0.28 (-1.66%)

06:26
07/24/17
07/24
06:26
07/24/17
06:26
Periodicals
Smith says U.S. should block Ant, MoneyGram deal, NY Post reports »

Rep. Chris Smith, the…

BABA

Alibaba

$151.89

-0.22 (-0.14%)

MGI

MoneyGram

$16.56

-0.28 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$45.30

-0.35 (-0.77%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Upgrade
MasTec rating change  »

MasTec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Aug

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Hot Stocks
Wells Fargo ordered to reinstate whistleblower, pay $577K in back wages, damages »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

MIK

Michaels

$19.02

0.22 (1.17%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Upgrade
Michaels rating change  »

Michaels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$66.00

-0.36 (-0.54%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Conference/Events
Citi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Periodicals
Didi Chuxing, SoftBank to invest $2B in ride-hail startup Grab, Recode says »

Chinese ride-hailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

, MET

MetLife

$54.65

0.07 (0.13%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Initiation
Brighthouse Financial, MetLife initiated  »

Brighthouse Financial…

BHF

Brighthouse Financial

MET

MetLife

$54.65

0.07 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

ACM

Aecom

$32.02

-0.25 (-0.77%)

06:19
07/24/17
07/24
06:19
07/24/17
06:19
Downgrade
Aecom rating change  »

Aecom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TEVA

Teva

$32.64

0.21 (0.65%)

06:18
07/24/17
07/24
06:18
07/24/17
06:18
Periodicals
Teva to cut Israeli workforce, mainly in production, Reuters reports »

Teva is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 30

    Aug

INTU

Intuit

$134.84

-0.51 (-0.38%)

06:17
07/24/17
07/24
06:17
07/24/17
06:17
Conference/Events
Intuit management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.